GAPVAC

Glioma Actively Personalized Vaccine Consortium

CoordinatorImmatics Biotechnologies (Germany) ; ACADEMISCH ZIEKENHUIS LEIDEN ; Technion – Israel Institute of Technology ; Universität Heidelberg ; INSTITUT CATALA DE LA SALUT ; Eberhard Karls University Tuebingen ; REGION HOVEDSTADEN ; University of Southampton ; IMMUNOLOGISCHE KREBS-THERAPIE EV ; BIONTECH AG ; BCN PEPTIDES S.A ; University of Glasgow ; University of Geneva
Grant period2012-11-01 - 2017-01-31
Funding bodyEuropean Union
Call numberFP7-HEALTH-2012-INNOVATION-1
Grant number305061
IdentifierG:(EU-Grant)305061

     

Recent Publications

There are no publications


 Record created 2014-10-20, last modified 2023-02-28



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)